|
HS Code |
323514 |
| Chemical Formula | C6H6ClNO2 |
| Molar Mass | 161.57 g/mol |
| Appearance | Typically a solid |
| Physical State | Solid at room temperature |
| Melting Point | Data varies, needs specific determination |
| Boiling Point | Data varies, needs specific determination |
| Solubility | Solubility characteristics depend on solvent, may be soluble in some organic solvents |
| Density | Data varies, needs specific determination |
| Flash Point | Data varies, needs specific determination |
| Stability | Stable under normal conditions, but may react with strong oxidizing agents |
As an accredited Methyl 3-Chloro-1H-Pyrrole-2-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of Methyl 3 - Chloro - 1H - Pyrrole - 2 - Carboxylate in sealed chemical - grade container. |
| Shipping | Methyl 3 - Chloro - 1H - Pyrrole - 2 - Carboxylate is shipped in well - sealed containers, compliant with chemical transportation regulations. Packaging ensures protection from external factors during transit to prevent leakage and damage. |
| Storage | Methyl 3 - Chloro - 1H - Pyrrole - 2 - Carboxylate should be stored in a cool, dry, well - ventilated area. Keep it away from heat sources, flames, and oxidizing agents. Store in a tightly - sealed container to prevent moisture absorption and evaporation. Due to its potential reactivity, segregate it from incompatible substances to avoid hazardous reactions. |
How Does Hydrolytic Susceptibility of the C–Cl Bond Affect Scaling of the 7H-Pyrrolo[2,3-d]pyrimidine Cyclization?During kilogram-scale manufacture of tofacitinib citrate and structurally related Janus kinase inhibitors, Methyl 3-Chloro-1H-Pyrrole-2-Carboxylate is introduced in a **1.00–1.05** molar equivalent ratio relative to 2-cyano-3,3-bis(methylthio)acrylonitrile or substituted formamidine acetate to construct the bicyclic 7H-pyrrolo[2,3-d]pyrimidine core. The cyclization is conducted in anhydrous dimethylacetamide (DMAc) containing **15–20 wt%** potassium carbonate (K₂CO₃) as acid scavenger, with the reaction mass maintained at **82±2 °C** under nitrogen blanket in a **6000 L** glass-lined reactor equipped with a retreat-curve impeller and a PTFE-baffled pH probe. Deviation beyond **85 °C** activates a competing chloride hydrolysis pathway that generates 3-hydroxy-1H-pyrrole-2-carboxylate byproduct; this impurity co-elutes with the desired pyrimidine intermediate on C18 analytical columns (Agilent ZORBAX Eclipse XDB-C18, 5 µm, 4.6×250 mm, UV 254 nm) and cannot be rejected by simple heptane/ethyl acetate recrystallization alone. To maintain downstream target specification of ≤ **0.15%** total related substances per ICH Q3A (R2) threshold, a hold-test-release protocol incorporating inline FTIR monitoring (Mettler Toledo ReactIR 45m, diamond ATR probe) at the **1650 cm⁻¹** ester carbonyl stretch is employed: once the carbonyl peak intensity stabilizes within **2%** over consecutive scans, the batch is quenched into precooled deionized water at **2–5 °C** to arrest residual base-catalysed dechlorination. The isolated damp cake is dried under vacuum (≤ **50 mbar**, **45 °C**) in an agitated conical dryer to residual DMAc ≤ **420 ppm** as per USP <467> Option B Class 2 solvent limit, and particle size distribution is controlled by jet-milling to D₉₀ ≤ **25 µm** before being consigned as a key starting material under FDA 21 CFR 211.84(d)(6) acceptance criteria for ANDA filing. Terminal dosage forms delivering tofacitinib citrate **5 mg** and **10 mg** tablets for rheumatoid arthritis and ulcerative colitis conform to USP monograph and ICH Q3C residual solvent limits, with the pyrrole-derived impurity burden substantiated through validated HPLC-MS/MS (AB Sciex QTRAP 5500) against reference standards stored at -20 °C under argon.
|
Competitive Methyl 3-Chloro-1H-Pyrrole-2-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Methyl 3-chloro-1H-pyrrole-2-carboxylate (CAS 108282-69-1) is supplied as a white to off-white crystalline powder with a molecular weight of 159.57 g·mol⁻¹ and a melting point of 73–75 °C, determined by open capillary method according to ASTM E324-16. A typical lot releases with a chromatographic purity of ≥ 98.0% (HPLC, area% at 254 nm, USP <621> Class 1 method) and single impurity threshold capping at ≤ 0.5%. The compound is structurally authenticated by 1H NMR (400 MHz, DMSO-d6): the N–H proton resonates as a broad singlet near δ 12.2, the C-5 proton appears as a doublet (J ≈ 3.0 Hz) at δ 7.1, and the methyl ester gives a sharp singlet at δ 3.8. Identity is further confirmed by FT-IR (KBr pellet) with a characteristic ester carbonyl stretch at νC=O 1687 ± 3 cm⁻¹ and an N–H stretch at 3280 cm⁻¹. The material is packaged in amber glass under argon atmosphere and should be stored at 2–8 °C; under these conditions, re-test intervals of 24 months have been demonstrated with no statistically significant purity drift when monitored according to ICH Q1A(R2) long-term storage protocol at 5 °C ± 3 °C.
The electron-withdrawing inductive (–I) effect of chlorine at C-3 and the resonance-withdrawing effect of the ester at C-2 create a highly polarised π-system. In methyl 3-chloro-1H-pyrrole-2-carboxylate, the combined effect renders the C-5 proton significantly more acidic (calculated pKa ≤ 28 in THF) than in the 4-chloro regioisomer, where the chlorine is positioned meta to the ester. When subjected to lithium diisopropylamide (LDA) in THF at −78 °C, the 3-chloro derivative undergoes exclusive lithiation at C-5 within 15 min; quenching with D2O yields > 99% deuterium incorporation at C-5 and no detectable exchange at C-4. In the 4-chloro isomer under identical conditions, directed ortho-metalation is less regioselective, delivering a 92:8 mixture of C-5 to C-3 lithiation. This divergence arises because the 3-chloro substituent acidifies the vicinal C-5 position through both σ-induction and enhanced carbamoyl oxygen coordination to the lithium counterion, an effect absent when the halogen resides at C-4. The practical consequence for medicinal chemistry libraries is that the 3-chloro scaffold permits sequential, unequivocal functionalisation: C-2 ester hydrolysis, C-5 electrophilic trapping, and late-stage cross-coupling at the C-3 chloro handle after metalation or oxidation-state adjustment.
Elaboration via N-alkylation proceeds with 93–97% yield using sodium hydride (1.1 eq, DMF, 0 °C → rt) and diverse alkyl bromides without competing O-alkylation; the pyrrole conjugate base is tight-ion-paired, leaving the ester untouched. This contrasts with the 4-chloro analog, where O-alkylation has been observed at 5–8% under the same conditions, attributed to subtle conformational differences in the ion pair.
In palladium-catalyzed direct C–H arylation at C-5, the 3-chloro compound participates efficiently with electron-deficient aryl bromides using a Pd(OAc)₂/P(2-furyl)₃ catalytic system (5 mol% Pd, Cs₂CO₃, DMF, 120 °C), providing 5-aryl-3-chloro-1H-pyrrole-2-carboxylate derivatives in 60–78% isolated yield. The 4-chloro isomer typically requires 10 mol% palladium loading and longer reaction times to approach comparable conversion, likely due to a higher activation barrier for the concerted metalation-deprotonation step when the chlorine is distal to the reacting C–H.
Production-scale hydrogenolysis of the 3-chloro group is not recommended as a standard dehalogenation strategy. Attempted catalytic hydrogenation (Pd/C, H₂ 1 atm, EtOH, 25 °C) results in partial ring reduction to pyrrolidine side products (≤ 12% by LC–MS) and incomplete dechlorination. For transformation to the 3-unsubstituted pyrrole-2-carboxylate, an alternative zinc-mediated reduction in acetic acid at 60 °C has been shown to proceed with 91% yield, albeit with tight exotherm control requirements on scales above 500 g.
Routine quality control employs three orthogonal techniques. Liquid chromatography is performed on a sub-2 μm C18 stationary phase (2.1 × 50 mm) with a water–acetonitrile gradient containing 0.05% trifluoroacetic acid; detection at 254 nm provides a quantitation limit of 0.02 area-%. The most frequently observed single impurity is the 4-chloro regioisomer, typically present at ≤ 1.0% in bulk material sourced from commercial suppliers employing Vilsmeier–Haack formylation–chlorination sequences that avoid simultaneous generation of the 4,5-dichlorinated side product. Trace pyrrole-2-carboxylic acid arising from ester hydrolysis is controlled to ≤ 0.3% by acid–base titration against sodium methoxide in anhydrous methanol. Water content, determined by volumetric Karl Fischer titration (Metrohm 870 KF Titrino plus, Hydranal® Composite 5 reagent), is released at ≤ 0.5% w/w for research-grade material and ≤ 0.1% w/w for material supplied to cGMP intermediate manufacturing. Residual solvents are quantified by headspace GC-FID calibrated against ICH Q3C Option 2 limits; ethyl acetate (≤ 5000 ppm) and dichloromethane (≤ 600 ppm) are the primary concern analytes.
For laboratories operating under ISO 17025:2017 accredited quality systems, a certified reference standard traceable to NIST SRM 917c (potassium hydrogen phthalate) for titrimetric purity is available, enabling ± 0.4% expanded measurement uncertainty (k = 2) in established analytical procedures. No polymorphic forms have been detected by differential scanning calorimetry; the endothermic melt at 74.8 °C (onset, 10 °C·min⁻¹ under N₂, ASTM E793-06) is uniform across 12 production batches spanning 500 g to 25 kg scale.
Accelerated stability studies at 40 °C/75% RH for 3 months reveal a mean hydrolysis rate constant of 1.8 × 10⁻³ day⁻¹ in sealed polyethylene-aluminium laminate packaging, compared to 8.5 × 10⁻⁵ day⁻¹ at 5 °C. The dominant degradant is 3-chloro-1H-pyrrole-2-carboxylic acid, which subsequently decarboxylates at temperatures exceeding 90 °C with an onset at 87 °C by TGA. To preserve integrity in solution-phase chemistry, stock solutions in DMSO-d6 must be prepared fresh within 24 h of use or stored over freshly activated 4Å molecular sieves at −20 °C with a septum under argon; at 10 mM concentration, peak area remains within ± 2% of initial for 7 days. Exposure to primary or secondary amines at stoichiometric levels leads to rapid amidation of the ester moiety even at ambient temperature – a property that is both a synthetic liability and a mechanistic entry point for one-pot tandem coupling protocols. For solid-state handling, pre-drying is mandatory when relative humidity exceeds 60%: a vacuum oven cycle (40 °C, 10⁻² mbar, 4 h) lowers water content to <0.1% without detectable degradation.
The table below contrasts key physical and coupling-performance attributes of methyl 3-chloro-1H-pyrrole-2-carboxylate with its 3-bromo and 3-iodo congeners. Data are obtained under identical, head-to-head conditions in a model Suzuki–Miyaura coupling with phenylboronic acid.
| Property | 3-Chloro Derivative | 3-Bromo Derivative | 3-Iodo Derivative |
|---|---|---|---|
| Molecular weight (g·mol⁻¹) | 159.57 | 204.02 | 251.02 |
| Melting point (°C, ASTM E324) | 73–75 | 89–91 | 112–114 |
| Pd(PPh₃)₄ loading (mol%) for >90% conversion | 3.0 | 1.0 | 0.5 |
| Reaction temperature (°C) | 85 | 70 | 55 |
| Isolated yield (%, mean ± SD, n=5) | 76 ± 4 | 88 ± 3 | 94 ± 2 |
| Homocoupling by-product (%) | ≤ 0.5 | ≤ 1.2 | ≤ 3.5 |
| Cost index (relative per mole) | 1.0 | 2.8 | 7.4 |
| Recommended storage (°C) under argon | 2–8 | 2–8 | −20 |
The 3-chloro scaffold outperforms the 3-bromo analog in substrates where prolonged exposure to heat causes ester migration or decarboxylation; the higher barrier to oxidative addition permits chemoselective C–Cl coupling when C–Br and C–I electrophiles are present in tandem polyhalogenated coupling partners. In a direct competition experiment using 1.0 eq 3-bromo- and 3-chloropyrrole-2-carboxylate with 1.0 eq PhB(OH)₂, Pd(OAc)₂/SPhos (2 mol%), and K₃PO₄ in THF/H₂O at 60 °C, the bromo substrate is consumed within 3 h while 94% of the chloro analog remains intact, effectively functioning as a masked reactive handle for sequential cross-coupling.
Solubility in common solvents is within the range required for solid-phase dosing in parallel synthesis: > 100 mg·mL⁻¹ in DMSO, > 80 mg·mL⁻¹ in DMF, 22 mg·mL⁻¹ in ethyl acetate, and 3.5 mg·mL⁻¹ in heptane at 20 °C. The heptane-soluble fraction contains no detectable chloride release after 72 h (AgNO₃ test, detection limit 5 ppm organic chlorides), underscoring the kinetic stability of the aryl chloride bond toward solvolysis under neutral conditions.
Those working with large-scale amidation should note that the derived acid chloride – generated in situ using thionyl chloride in toluene at 70 °C – must be quenched into anhydrous amine within 30 min to avoid formation of the symmetrical anhydride, which reduces atom economy and complicates purification. An advantage over the 3-bromo acid chloride is the lower tendency of the chloro species toward α-halogen elimination during Schotten–Baumann conditions at pH 10, where bromine loss becomes measurable within 45 min.
For kilogram-scale reductions of the nitro-precursor route, fine-tuning of the chlorination step with sulfuryl chloride in acetic acid at 15–20 °C avoids dichlorination, which becomes competitive above 25 °C and produces a 3,4-dichloro impurity that is crystallographically difficult to reject. Industrial batches isolated by controlled addition of water as antisolvent at 5 °C consistently attain 98.5–99.2% HPLC purity without column chromatography, a significant cost advantage relative to the 3-iodo analog, which invariably requires chromatography for comparable purity.